Medicare Enrolled

Dr. Sandeep Anreddy, MD

Cardiovascular Disease · Clermont, FL
Practice pattern: Cardiac Imaging— Practice with significant diagnostic imaging and stress testing
Low-engagement
2080 OAKLEY SEAVER DR STE 130, Clermont, FL 34711
3218416444
In practice since 2007 (18 years)
NPI: 1326257692 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Anreddy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anreddy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Anreddy

Dr. Sandeep Anreddy is a cardiovascular disease in Clermont, FL, with 18 years in practice. Based on federal Medicare data, Dr. Anreddy performed 3,971 Medicare services across 2,909 unique beneficiaries.

Between the years covered by Open Payments, Dr. Anreddy received a total of $1,284 from 21 pharmaceutical and/or device companies across 61 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Anreddy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 29% volume in FL$ $1,284 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,971
Medicare services
Top 29% in FL for cardiovascular disease
2,909
Unique beneficiaries
$133
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~221 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Regadenoson injection (Lexiscan) for heart stress test745$46$149
Echocardiogram, transthoracic535$141$560
Technetium tc-99m tetrofosmin, diagnostic, per study dose365$324$409
Office visit, established patient (30-39 min)354$90$200
Hospital follow-up visit, high complexity253$95$202
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician247$44$190
Nuclear medicine studies of heart muscle at rest and with stress and spect183$332$1,193
Electrocardiogram (EKG), 12-lead166$11$45
Initial hospital admission, high complexity151$135$382
New patient office visit (45-59 min)139$111$306
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician112$11$38
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician110$16$57
Office visit, established patient, complex (40-54 min)82$135$319
Remote pacemaker monitoring, 90 days62$22$87
Remote pacemaker/defibrillator monitoring, 90 days62$16$64
Programming of dual lead pacemaker system61$59$146
Hospital follow-up visit, moderate complexity56$62$135
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries56$319$998
Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan28$2,135$5,500
Nuclear medicine study of heart muscle blood flow by pet28$142$445
Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional28$20$63
Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional28$625$1,764
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional27$47$255
Nuclear medicine study of heart pumping function by labeling red blood cells with measurement of internal blood volume ejected with every beat over multiple cycles22$159$580
Injection, perflutren lipid microspheres, per ml17$35$185
Programming of single lead pacemaker system16$47$126
EKG interpretation and report13$7$24
Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries13$123$215
New patient office visit, complex (60-74 min)12$162$472
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.5% high complexity
37.6% medium
43.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,284
Total received (2018-2024)
Avg $214/year across 6 years
Bottom 30% in FL for cardiovascular disease
21
Companies
61
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,129 (88.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$146 (11.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$168
2023
$400
2022
$552
2021
$16
2019
$41
2018
$107

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$236
Boehringer Ingelheim Pharmaceuticals, Inc.
$204
Merck Sharp & Dohme LLC
$171
Astellas Pharma US Inc
$146
Amgen Inc.
$87
Abbott Laboratories
$70
PFIZER INC.
$48
ABIOMED
$41
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$35
AstraZeneca Pharmaceuticals LP
$34
Alnylam Pharmaceuticals Inc.
$32
Daiichi Sankyo Inc.
$27
Actelion Pharmaceuticals US, Inc.
$25
CARDIVA MEDICAL, INC.
$19
AltaThera Pharmaceuticals LLC
$19
E.R. Squibb & Sons, L.L.C.
$18
Kiniksa Pharmaceuticals, Ltd.
$18
SANOFI-AVENTIS U.S. LLC
$16
Esperion Therapeutics, Inc.
$16
Boston Scientific Corporation
$15
Z-Medica, LLC
$8
Top 3 companies account for 47.6% of total payments
Associated products mentioned in payments ›
Arcalyst · BRILINTA · CHANTIX · Circulatory Support · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · INJECTAFER · Impella · JARDIANCE · LEQVIO · Lexiscan · LifeVest · MITRACLIP · MULTAQ · NEXLETOL · ONPATTRO · OPSUMIT · QuikClot · Repatha · Sotalol Hydrochloride · VERQUVO · VYNDAQEL · Vascular Closure Device · WATCHMAN Access System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $32 per 100 Medicare services performed
Looking for a cardiovascular disease in Clermont?
Compare cardiovascular diseases in the Clermont area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
154
Per 100K population
38.6
County median income
$69,956
Nearest hospital
ORLANDO HEALTH SOUTH LAKE HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Anreddy is a cardiac imaging specialist, with above-average Medicare volume (top 29% in FL), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Anreddy experienced with regadenoson injection (lexiscan) for heart stress test?
Based on Medicare claims data, Dr. Anreddy performed 745 regadenoson injection (lexiscan) for heart stress test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anreddy receive payments from pharmaceutical companies?
Yes. Dr. Anreddy received a total of $1,284 from 21 companies across 61 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anreddy's costs compare to other cardiovascular diseases in Clermont?
Dr. Anreddy's average Medicare payment per service is $133. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anreddy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →